Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis.
Pyrpasopoulou
Athina
A
2nd Propedeutic Department of Internal Medicine, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. a.pyrpasopoulou@doctors.org.uk
Douma
Stella
S
Vassiliadis
Themistoklis
T
Chatzimichailidou
Sofia
S
Triantafyllou
Areti
A
Aslanidis
Spyros
S
D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D005260:Female; D019694:Hepatitis B, Chronic / Q000276:immunology* / Q000821:virology; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D008875:Middle Aged; D012008:Recurrence; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab